Form D · Pharmaceuticals
Theron Pharmaceuticals, Inc.
Sunnyvale, CA · CIK 0001458056
Offering snapshot reported Aug 6, 2015 · SEC filing
- Reported sold
- $409K Offering amount: $750K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 24, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 6, 2015 | Initial | $409,099 | No comparison | 5 | SEC filing |
| May 19, 2011 | Initial | $662,550 | No comparison | 5 | SEC filing |
| May 14, 2010 | Initial | $957,670 | No comparison | 5 | SEC filing |
| May 11, 2009 | Initial | $180,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-245161
Source: Form D, filed Aug 6, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Allan Kramer, M.D. | Director |
| James W. Larrick | Director |
| Jurg R. Pfister | Director, Executive |
| Cary Queen, Ph.D. | Director |
| Meenakshi Sundaram Venkatraman | Executive |
| Xiaoming Zhang | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
365 San Aleso Avenue
Sunnyvale, CA, 94085
Sunnyvale, CA, 94085